Pharmacological treatment of presbyopia

Article Sidebar

PDF (Język Polski)


Published: Dec 29, 2017
DOI: https://doi.org/10.24292/01.OT.291217.07
Keywords:
presbyopia, accommodation, pharmacological therapy, eye drops

Main Article Content

Andrzej Grzybowski
1. Katedra Okulistyki, Uniwersytet Warmińsko-Mazurski w Olsztynie. 2. Instytut Okulistycznych Badań Naukowych w Poznaniu
Małgorzata Mimier
Katedra i Klinika Okulistyki, Uniwersytet Medyczny we Wrocławiu
Marta Misiuk-Hojło
Katedra i Klinika Okulistyki, Uniwersytet Medyczny we Wrocławiu

Abstract

Presbyopia is a physiological condition associated with ageing, affecting people after 40 y.o., that results in gradually worsening an ability to focus on close objects. Spectacles and contact lenses are the most popular tools used to correct presbyopia, unfortunately their usage may be bothersome. Pharmacological treatment of presbyopia is based on using ophthalmic drops, which by impact on ciliary muscle, changing pupil size and elasticity can improve near vision. Article presents current research status concerning pharmacological correction of presbyopia.

Downloads

Download data is not yet available.

Article Details

How to Cite
1.
Grzybowski A, Mimier M, Misiuk-Hojło M. Pharmacological treatment of presbyopia. Ophthatherapy [Internet]. 2017Dec.29 [cited 2024Nov.22];4(4):237-40. Available from: https://journalsmededu.pl/index.php/ophthatherapy/article/view/584
Issue
Vol 4 No 4 (2017)
Section
Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Copyright: © Medical Education sp. z o.o. License allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.

Address reprint requests to: Medical Education, Marcin Kuźma (marcin.kuzma@mededu.pl)

References

1. Burd HJ, Judge SJ, Flavell MJ. Mechanics of accommodation of the human eye. Vision Res. 1999; 39: 1591-5.
2. Balal S, Gil-Cazorla R, Naroo S et al. Refractive surgery’s Holy Grail. Eyedrops for presbyopia. The Ophthalmologist. 2017; 07: 18-29.
3. Benozzi J, Benozzi G, Orman B. Presbyopia: a new potential pharmacological treatment. Med Hypothesis Discov Innov Ophthalmol. 2012; 1: 3-5.
4. Schalnus R. Topical nonsteroidal anti-inflammatory therapy in ophthalmology. Ophthalmologica. 2003; 217: 89-98.
5. Patel S, Salamun F, Matovic K. Pharmacological correction of presbyopia. Poster presented at the XXXI congress of the ESCRS. 2013. Amsterdam. Online: http://escrs.org/amsterdam2013/programme/posters-details.asp?id=19804.
6. Abdelkader A. Improved Presbyopic Vision With Miotics. Eye Contact Lens. 2015; 41: 323-7.
7. Renna A, Vejarano LF, De la Cruz E et al. Pharmacological Treatment of Presbyopia by Novel Binocularly Instilled Eye Drops: A Pilot Study. Ophthalmol Ther. 2016; 5: 63-73.
8. Renna A, Alió JL, Vejarano LF. Pharmacological treatments of presbyopia: a review of modern perspectives. Eye Vis (Lond). 2017; 4: 9.